Buscar
Congreso SOLACI

Artículos del autor

Dr. Omar Tupayachi

Member of the Editorial Board of solaci.org
Acute coronary syndromes

DCB-BIF Trial: Randomized Study of Side Branch Drug-Coated Balloon Angioplasty Following Provisional Stenting

Coronary bifurcations present technical challenges that should be addressed for adequate coronary geometry. The first treatment option...
Dr. Omar Tupayachi -
Chronic Coronary Syndromes

Coronary Sinus Reducer for Refractory Angina: Notes from the REDUCER-I Study

Refractory angina is defined as the presence of ischemic symptoms that cannot be controlled through optimal medical...
Dr. Omar Tupayachi -
Peripheral vascular disease

Trends in the Treatment of Critical Lower Limb Ischemia

Approximately 25% of patients with critical lower limb ischemia (CLLI) face amputation within the first year after...
Dr. Omar Tupayachi -
Structural heart disease

PULSE Registry Subanalysis: Radial vs. Femoral Secondary Access

In view of its lower complications rate, the transfemoral approach is the most used in transcatheter aortic...
Dr. Omar Tupayachi -
Acute coronary syndromes

Direct Oral Anticoagulants for Ventricular Thrombus After STEMI

While the incidence of intracavitary thrombi after acute myocardial infarction (AMI) has decreased thanks to optimized primary...
Dr. Omar Tupayachi -
Structural heart disease

Secondary Access in TAVI: Is Transradial Approach our Best Bet?

In some countries, transcatheter aortic valve implantation (TAVI) has become the treatment of choice for patients with...
Dr. Omar Tupayachi -
Acute coronary syndromes

TENDERA: Comparing Conventional vs. Distal Transradial Occlusion for Coronary Interventions

Supported by robust data, favorably compared against the transfemoral, the transradial approach has consolidated as the safest...
Dr. Omar Tupayachi -
Structural heart disease

TricValve Transcatheter Bicaval Valve System for Severe Tricuspid Insufficiency: Events at One Year

TricValve is the first bicaval valve system to obtain CE-Mark approval. This device heterotopic device eliminates tricuspid...
Dr. Omar Tupayachi -

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Dr. Andrés Rodríguez - 0
Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Prospective Analysis of the Feasibility of the PASCAL System for Transcatheter Mitral Repair: OneForAll Registry

solaci - 0
Courtesy of Dr. Juan Manuel Pérez. Mitral transcatheter edge-to-edge repair (M-TEER) is an effective option for patients with severe mitral regurgitation who are at high...

Left Bundle Branch Block after TAVR: What Is Its Impact?

solaci - 0
Courtesy of Dr. Juan Manuel Pérez. Left bundle branch block (LBBB) is a common complication following transcatheter aortic valve replacement (TAVR), which can be either...

Noticias Institucionales

Watch our event on Evidence and Controversies of Renal Denervation in 2025

solaci - 0
You can now watch our event, held in collaboration with Medtronic, titled "Evidence and Controversies of Renal Denervation in 2025." The event featured international experts...

March 26 – SOLACI Webinar: Evidence and Controversies in Renal Denervation in 2025

solaci - 0
The Latin American Society of Interventional Cardiology invites you to a new virtual event supported by Medtronic. On this occasion, we will hold a 60-minute...

Uruguay Sessions 2025 | Young Interventional Cardiologists Contest

solaci - 0
Call for Case Submission LI SOLACI Regional Sessions – 16° Southern Cone  It is with great pleasure that we hereby invite all young Latin American cardiologists...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad